Crossmark

Tackling a Major Deficiency of Diversity in Alzheimer's Disease Therapeutic Trials: An CTAD Task Force Report

Crossref DOI link: https://doi.org/10.14283/jpad.2022.50

Published Print: 2022-07

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Raman, Rema

Aisen, P.

Carillo, M.C.

Detke, M.

Grill, J.D.

Okonkwo, O.C.

Rivera-Mindt, M.

Sabbagh, M.

Vellas, B.

Weiner, M.

Sperling, R.
License Information

Text and Data Mining valid from 2022-07-01

Text and Data Mining valid from 2022-07-01

Version of Record valid from 2022-05-13
More Information

This article is maintained by: Elsevier

Article Title: Tackling a Major Deficiency of Diversity in Alzheimer's Disease Therapeutic Trials: An CTAD Task Force Report

Journal Title: The Journal of Prevention of Alzheimer's Disease

CrossRef DOI link to publisher maintained version: https://doi.org/10.14283/jpad.2022.50

Content Type: article

Copyright: Copyright © 2022 THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher. Published by Elsevier Masson SAS